1,317
Views
23
CrossRef citations to date
0
Altmetric
Case Report

Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation

, , , , &
Pages 855-857 | Received 30 Oct 2007, Accepted 30 Jan 2008, Published online: 02 Dec 2008

References

  • EB Chevretton, RDR McRae, and JB Booth. Mastoidectomy packs: xeroform or BIPP. J Laryngol Otol 1991; 105:916–917.
  • RR Sharma, IP Cast, RM Redfern, and C O'Brien. Extradural application of bismuth iodoform paraffin paste causing relapsing bismuth encephalopathy: a case report with CT and MRI studies. J Neurol Neurosurg Psychiatry 1994; 57:990–993.
  • AM Bridgeman, and AC Smith. Iatrogenic bismuth poisoning – a case report. Aust Dent J 1994; 39:279–281.
  • RC Baselt. Bismuth. In: RC Baselt. Disposition of Toxic Drugs and Chemicals in Man. 7th ed. Foster City, California, USA: Biomedical Publications, 2004; 119–121.
  • A Nigam, and MC Allwood. BIPP – How does it work. Clin Otolaryngol Allied Sci 1990; 15:173–175.
  • A Slikkerveer, and FA de Wolff. Pharmacokinetics and toxicity of bismuth compounds. Med Toxicol Adverse Drug Exp 1989; 4:303–323.
  • M Stoltenberg. Retrograde axonal transport of bismuth: an autometallographic study. Acta Neuropathol (Berl) 2001; 101:123–128.
  • K Lavelle, DJ Doedens, SA Kleit, and RB Forney. Iodine absorption in burn patients treated topically with povidone-iodine. Clin Pharmacol Ther 1975; 17:355–362.
  • A Slikkerveer. Bismuth poisoning and chelation. J Clin Tox 1993; 31:365–366.
  • Dimercaprol Injection BP (Sovereign Medical) Summary of Product Characteristics.. http://www.emc.medicines.org.uk/eMC/assets/c/html/displayDocPrinterFriendly.asp?DocumentID=10794. Accessed 7 January 2008.
  • A Slikkerveer, HB Jong, RB Helmich, and FA de Wolff. Development of a therapeutic procedure for bismuth intoxication with chelation agents. J Lab Clin Med 1992; 119:529–537.
  • A Slikkerveer, LA Noach, GNJ Tytgat, GB Van der Voet, and FA de Wolff. Comparison for enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D, L-2,3-dimercaptopropane-1-sulfonic acid. Analyst 1998; 123:91–92.
  • RJ Playford, CH Matthews, MJ Campbell, HT Delves, KK Hla, HJ Hodgson, and J Calam. Bismuth induced encephalopathy in a patient with chronic renal failure. Gut 1990; 31:359–360.
  • PE Stevens, DF Moore, IM House, GN Volans, and DJ Rainford. Significant elimination of Bismuth by Haemodialysis with a new heavy-metal chelating agent. Nephrol Dial Transplant 1995; 10:696–698.
  • K Hruby, and A Donner. 2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning. Med Toxicol Adverse Drug Exp 1987; 2:317–323.
  • Poisoning with Toxic Metals and Organometallic Compounds. In RJ Flanagan. Antidotes. 1st ed. London: Taylor & Francis, 2001; 60–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.